RxDoctor Payments DataLook up a doctor →

Benjamin Heller

Ophthalmology · Phoenix, AZNPI 1346655099

Payments from drug & device makers

$1,096,151in general payments, 2019–2025

Across 538 payments — averaging $2037.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Oyster Point Pharma, Inc.$571K
  • Glaukos Corporation$435K
  • Alcon Research LLC$68K
  • Johnson & Johnson Surgical Vision, Inc.$14K
  • Rxsight Inc$2K
  • Regeneron$1K
  • plus $4K from 10 others
$42,281in research payments, 2019–2025

Across 88 payments — averaging $480.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$42K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,096,151 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.

See all ophthalmology providers in Arizona

Medicare billing

Part B allowed, 2024
$254,004
Medicare patients
514
Services billed
1,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →